Publication | Open Access

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial

UrologyOncologyGenitourinary CancerCastration-resistant Prostate CancerCancer TreatmentProstatic DiseaseMedicineBone-metastasis-free SurvivalPhase 3